Purple Biotech Ltd.

Regulatory Filings • Jun 30, 2020

_________ false

����� ����� ��"�	2 352
KITOV PHARMA LTD
Corporation no: 520031238	12724
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	29/06/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-060454	Time of broadcast: 21:58 21:55:43

Complementary report for a report sent on date 25/06/2020 whose reference number was 2020-02-058657

Main details added/ completed:	Amends the initial submission of the Form 6-K to replace Form of Placement Agent Warrant included as Exhibit 4.2 in the initial submission to reflect the correct exercise price of $1.125 per ADS, instead of $0.90 as stated in the original exhibit

---

Immediate report on other matterDon't use this form if there is more adequate one

����� ������ ���� 25.6.2020- ������ ���� ������ ��"� �� ����� ������ ������ ����� �����
Attached file ea123580-6ka1_kitovpharmaEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 23/06/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: adim@kitovpharma.com 1
Israel